Cargando…
HDAC8 and STAT3 repress BMF gene activity in colon cancer cells
Histone deacetylase (HDAC) inhibitors are undergoing clinical trials as anticancer agents, but some exhibit resistance mechanisms linked to anti-apoptotic Bcl-2 functions, such as BH3-only protein silencing. HDAC inhibitors that reactivate BH3-only family members might offer an improved therapeutic...
Autores principales: | Kang, Y, Nian, H, Rajendran, P, Kim, E, Dashwood, W M, Pinto, J T, Boardman, L A, Thibodeau, S N, Limburg, P J, Löhr, C V, Bisson, W H, Williams, D E, Ho, E, Dashwood, R H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237248/ https://www.ncbi.nlm.nih.gov/pubmed/25321483 http://dx.doi.org/10.1038/cddis.2014.422 |
Ejemplares similares
-
HDAC turnover, CtIP acetylation and dysregulated DNA damage signaling in colon cancer cells treated with sulforaphane and related dietary isothiocyanates
por: Rajendran, Praveen, et al.
Publicado: (2013) -
Nrf2 status affects tumor growth, HDAC3 gene promoter associations, and the response to sulforaphane in the colon
por: Rajendran, Praveen, et al.
Publicado: (2015) -
Histone deacetylase turnover and recovery in sulforaphane-treated colon cancer cells: competing actions of 14-3-3 and Pin1 in HDAC3/SMRT corepressor complex dissociation/reassembly
por: Rajendran, Praveen, et al.
Publicado: (2011) -
Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells
por: Rajendran, Praveen, et al.
Publicado: (2011) -
A role for low-abundance miRNAs in colon cancer: the miR-206/Krüppel-like factor 4 (KLF4) axis
por: Parasramka, Mansi A, et al.
Publicado: (2012)